PerformanceRiskValuationProfitabilityCashflowLiquidityESGRevenue & Geographic ExposureForecastFinancial GrowthIncome GrowthCashflow GrowthBalance Sheet Growth
Texas Instruments Incorporated (TXN)
205.980.01 (0.00%)
205.24 - 207.41
139.95 - 221.69
4.54M / 6.54M (Avg.)
37.59 | 5.48
Shows the trajectory of a company's cash-generation capacity. Consistent growth in operating and free cash flow suggests a robust, self-funding business model—crucial for value investors seeking undervalued, cash-rich opportunities.
-80.96%
Negative net income growth while MRVL stands at 120.09%. Joel Greenblatt would see a comparative disadvantage in bottom-line performance.
12.69%
D&A growth well above MRVL's 11.18%. Michael Burry would suspect heavier depreciation burdens that might erode net income unless top-line follows suit.
70.51%
Deferred tax of 70.51% while MRVL is zero at 0.00%. Bruce Berkowitz would see a partial difference that can matter for future cash flow if large in magnitude.
No Data
No Data available this quarter, please select a different quarter.
171.65%
Well above MRVL's 194.47% if positive yoy. Michael Burry would see a risk of bigger working capital demands vs. competitor, harming free cash flow.
No Data
No Data available this quarter, please select a different quarter.
163.16%
Inventory growth well above MRVL's 38.02%. Michael Burry would suspect potential future write-down risk if demand does not materialize.
No Data
No Data available this quarter, please select a different quarter.
175.28%
Lower 'other working capital' growth vs. MRVL's 671.41%. David Dodd would see fewer unexpected short-term demands on cash.
-5.56%
Negative yoy while MRVL is 6.84%. Joel Greenblatt would see a near-term net income or CFO stability advantage unless competitor invests or writes down more aggressively.
6.27%
Operating cash flow growth below 50% of MRVL's 562.36%. Michael Burry would see a serious shortfall in day-to-day cash profitability.
60.91%
Some CapEx rise while MRVL is negative at -86.44%. John Neff would see competitor possibly building capacity while we hold back expansions.
No Data
No Data available this quarter, please select a different quarter.
-46066.67%
Both yoy lines negative, with MRVL at -84.44%. Martin Whitman would suspect an environment with fewer attractive securities or a strategic pivot to internal growth.
133.33%
Proceeds from sales/maturities above 1.5x MRVL's 56.59%. David Dodd would confirm if the firm is capitalizing on strong valuations or freeing liquidity for expansions.
No Data
No Data available this quarter, please select a different quarter.
-969.75%
Both yoy lines negative, with MRVL at -2349.62%. Martin Whitman suspects a broader cyclical shift away from heavy investing across the niche.
No Data
No Data available this quarter, please select a different quarter.
-50.00%
Negative yoy issuance while MRVL is 13.53%. Joel Greenblatt sees a near-term advantage in avoiding dilution unless competitor invests more effectively with the new shares.
10.02%
Buyback growth of 10.02% while MRVL is zero at 0.00%. Bruce Berkowitz sees a modest per-share advantage that might accumulate if the stock is below intrinsic value.